Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 21, 2024; 30(7): 685-704
Published online Feb 21, 2024. doi: 10.3748/wjg.v30.i7.685
Published online Feb 21, 2024. doi: 10.3748/wjg.v30.i7.685
Table 9 Type of first decompensation event of non-acute and acute decompensating patients
| Type of first decompensation event | NAD-decompensating patients (n = 29) | AD-decompensating patients (n = 14) |
| (A) Slow/ grade 1 ascites formation [n (%)] | 14 (48.3) | / |
| (B) Mild (grade 1/2) hepatic encephalopathy [n (%)] | 6 (20.7) | / |
| (C) Jaundice in non-cholestatic cirrhosis [n (%)] | 9 (31) | / |
| A + B/A + C | 2/5 | |
| (D) Grade 2/3 ascites within less than 2 wk [n (%)] | / | 5 (35.7) |
| (E) Severe acutea hepatic encephalopathy [n (%)] | / | 4 (28.5) |
| (F) Acute gastrointestinal bleeding [n (%)] | / | 2 (14.3) |
| (G) Acute bacterial infection | / | 3 (21.5) |
- Citation: Dallio M, Romeo M, Vaia P, Auletta S, Mammone S, Cipullo M, Sapio L, Ragone A, Niosi M, Naviglio S, Federico A. Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis. World J Gastroenterol 2024; 30(7): 685-704
- URL: https://www.wjgnet.com/1007-9327/full/v30/i7/685.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i7.685